Skip to main content

Table 3 Functional enrichment of GO for part of DNB

From: Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers

Enriched items

Genes

p-value

Cell surface receptor signaling pathway (GO:0007166)

GCD3G, CD3D, CD8A, CD3E, CCR1, CD247, CXCR1, FADD, IL7R, IL17RA, IFNAR2, LILRB2, TNFSF10, MYD88, CCR5, LILRB3, CD2, KLRD1, CD14, CD27, CD28

5.57E-21

Immune response (GO:0006955)

IL18RAP, AQP9, CD8A, GZMA, CCR1, HLA-DMB, GZMH, IL7R, HLA-DMA, LILRB2, TNFRSF1B, TNFSF10, CCR5, IL4R, IRF8, ZAP70, HLA-DPA1, CD27, PTAFR, HLA-DRA

1.50E-13

T cell costimulation (GO:0031295)

CD3G, TRAC, CD3D, CD3E, LGALS1, CD247, LCK, HLA-DPA1, CD5, HLA-DRA, CD28

4.77E-12

T cell receptor signaling pathway (GO:0050852)

CD3G, TRAC, CD3D, CD3E, GATA3, CD247, LCK, ZAP70, HLA-DPA1, HLA-DRA, PIK3R2, CD28

1.61E-10

Apoptotic process (GO:0006915)

PRF1, GZMA, LGALS1, LY86, TGFBR2, FADD, GZMB, ZBTB16, GZMH, TNFSF10, MYD88, RIPK1, MAP3K1, CD2, CTSH, CD14

1.03E-07